THNR

Amplify Weight Loss Drug & Treatment ETF
THNR

$27.65
0.99%

Market Cap: $4.42M

0
Funds holding %
of 6,710 funds
–
Analysts bullish %

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

23.23% more ownership

Funds ownership: 0% [Q1] → 23.23% (+23.23%) [Q2]

See Fund Rankings

Research analyst outlook

We haven’t received any recent analyst ratings for THNR.

See Analyst Rankings

Financial journalist opinion

Positive
Zacks Investment Research
1 day ago
Tap the Weight-Loss Drug Market With These ETFs
Investors seeking to tap the boom in weight-loss drug treatment could consider these ETFs.
Tap the Weight-Loss Drug Market With These ETFs
Neutral
ETF Trends
1 month ago
Disruptive Theme of the Week: Playing Defense
When markets correct, it is a good time to revisit which equity market sectors are “defensive” themes. Certain products and services are nondiscretionary in nature that we cannot live without.
Disruptive Theme of the Week: Playing Defense
Positive
Zacks Investment Research
1 month ago
ETFs in Focus as Competition Heats Up in Weight Loss Drug Segment
Two companies, Eli Lilly (LLY) and Novo Nordisk (NVO), have so far dominated the weight-loss drug market. Now, Roche recently announced encouraging Phase I trial data for its new obesity drug candidate.
ETFs in Focus as Competition Heats Up in Weight Loss Drug Segment
Positive
Schwab Network
2 months ago
SILJ, HACK, THNR: Trends in Thematic Investing
Amplify Junior Silver Miners ETF (SILJ) is up 28% year-to-date. Christian Magoon discusses the outlook for cybersecurity stocks, as Amplify's Cybersecurity ETF (HACK) is up 8% year-to-date.
SILJ, HACK, THNR: Trends in Thematic Investing
Positive
ETF Trends
2 months ago
Top Themes in the First Half of 2024: Crypto, Chips, Ships & Silver
After a torrid risk-on run in the first quarter of 2024, markets cooled off a bit but ended the half still positive with mid-double-digit returns. Technology themes such as cryptocurrency and artificial intelligence helped propel markets higher.
Top Themes in the First Half of 2024: Crypto, Chips, Ships & Silver
Negative
Investopedia
2 months ago
Why Investors Haven't Feasted on Two New Weight-Loss ETFs
Two new weight-loss exchange-traded funds (ETFs) launched in May have yet to whet investors' appetite, possibly due to their expensive fees and concentrated bets.
Why Investors Haven't Feasted on Two New Weight-Loss ETFs
Neutral
ETF Trends
3 months ago
Finding Opportunity in Unloved Healthcare ETFs
Sometimes it feels like it's Nvidia's world and we all just live in it. Why bother with anything else?
Finding Opportunity in Unloved Healthcare ETFs
Positive
Zacks Investment Research
3 months ago
Play These New ETFs to Tap Lucrative Weight Loss Drug Market
Global obesity rates have nearly tripled since 1975, per WHO and Goldman Sachs. The growing usage of GLP-1 drugs in weight management now makes the industry a thriving one.
Play These New ETFs to Tap Lucrative Weight Loss Drug Market
Positive
ETF Trends
3 months ago
Amplify Debuts New Weight Loss Drug ETF
On Tuesday, Amplify entered the weight loss ETF space with the launch of the Amplify Weight Loss Drug & Treatment ETF (THNR). THNR operates with a net expense ratio of 0.59%.
Amplify Debuts New Weight Loss Drug ETF
See News Rankings